Daily Journal Staff Writer
Medical device developer TriVascular Technologies Inc. tapped Arnold & Porter LLP to help ready an initial public offering that could net the Santa Rosa-based company up to $100 million, according to a late Monday filing with the Securities and Exchange Commission.
Share volume and pricing details were not disclosed.
TriVascular makes stent grafts used to aid in the treatment of a...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In